A Study of Rofecoxib in the Treatment of Post-Operative Pain After Total Knee Joint Replacement (0966-259)

• Status: Terminated
• Trial end date: 2004-09-27
• Target enrollment: 0
• Participant gender: All

Summary

A study to compare pre-operative administration of rofecoxib versus post-operative administration of diclofenac or rofecoxib, respectively, in the treatment of post-operative pain after total knee joint replacement in patients with osteoarthritis of the knee.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Diclofenac; Rofecoxib

Criteria

Inclusion Criteria:

• Males or females at least 18 years of age who have osteoarthritis of the knee and have undergone total knee joint replacement.